Related Experiment Video
Updated: Jan 28, 2026

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018
A Case of Alveolar Bleeding from Clotting Abnormality by Cefmetazole
Eri Nakano1, Tsubasa Fukuoka1, Nao Takeuchi1
1Department of Internal Medicine, Suwa Central Hospital, Chino, Nagano, Japan.
Abstract:
Cephalosporins are one of the most commonly used first-line antibiotics. In this report, we describe the case of a patient who developed alveolar bleeding due to clotting abnormality following the use of cefmetazole, one of cephalosporins containing an N-methylthiotetrazole (NMTT) side chain. Compared to other antibiotics, cephalosporins with an NMTT side chain cause a higher degree of bleeding events. The bleeding tendency is caused by the depletion of vitamin K-dependent clotting factors via inhibition of the vitamin K epoxide reductase. This mechanism of action is the same as warfarin. Recent years have seen an increase in the number of patients using direct oral anticoagulants that do not require coagulation tests. As a consequence, there may be an increase in the number of bleeding events due to anticoagulant drugs and such antibiotics coprescription. Therefore, this case is an instructive lesson.
Insights
Certain cephalosporin antibiotics, like cefmetazole, can cause bleeding by depleting vitamin K-dependent clotting factors. This risk increases when used with direct oral anticoagulants, necessitating careful patient monitoring.
Area of Science:
- Pharmacology
- Internal Medicine
- Hematology
Background:
- Cephalosporins are widely used first-line antibiotics.
- Some cephalosporins possess an N-methylthiotetrazole (NMTT) side chain, linked to adverse effects.
- Vitamin K epoxide reductase inhibition is a known mechanism for certain drug-induced coagulopathies.
Observation:
- A case of alveolar bleeding secondary to clotting abnormality is reported.
- The patient developed this condition after cefmetazole administration.
- Cefmetazole contains the NMTT side chain, associated with increased bleeding risk.
Findings:
- Cephalosporins with NMTT side chains elevate bleeding event frequency.
- The mechanism involves vitamin K-dependent clotting factor depletion via vitamin K epoxide reductase inhibition.
- This action mirrors that of warfarin, a common anticoagulant.
Implications:
- Concurrent use of NMTT-containing cephalosporins and direct oral anticoagulants may increase bleeding events.
- This interaction poses a growing clinical concern due to the rising use of anticoagulants.
- Healthcare providers must be vigilant for bleeding risks in patients on combined therapies.
Related Concept Videos
Abnormal Proliferation
Bleeding in Fresh Concrete
Bleeding can cause several issues in the concrete structure. Sometimes, the rising water gets trapped beneath large aggregate...
Alveoli and Alveolar Ducts
Clot Retraction and Fibrinolysis
Respiratory System Abnormal Finding I: Inspection and Percussion
Inspection Findings
During an inspection, several findings may suggest the presence of respiratory distress or disease. Pursed-lip breathing, where exhalation is slowed by...
Cardiovascular System Abnormal Findings I: Inspection and Palpation
Abnormal findings observed during an inspection

